HopeStage
Back to all studies
Not Yet RecruitingNCT07562074

Transcranial Magnetic Stimulation for Depression in Multiple Sclerosis

Device studyAges 18–65Canada
The study in practice

Understand this study

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
CalgarySee all locations and recruitment
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateEstimated: June 15, 2026
Recruitment status
Not Yet Recruiting
Enrollment listed in the registry
20
Sponsor
University of Calgary
Sponsor type
University
Study type
Device
Intervention type
Device
Study phase
Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT07562074
Official title
Show the full official title

A Pilot Study: Dorsolateral Prefrontal Cortex Transcranial Magnetic Stimulation Target Engagement and Safety in Primary Progressive and Relapsing-remitting Multiple Sclerosis

Recruitment & locations

Not yet recruiting

Calgary

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Calgary, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Is this study still recruiting?

The registry lists this study as not yet recruiting.

Want to explore more studies?

Explore studies